Press Room

Find news and updates from PhRMA, representing the country’s leading biopharmaceutical research companies. Our members are committed to finding tomorrow’s cures and treatments for some of the most serious diseases such as cancer, Alzheimer’s disease, cystic fibrosis and Parkinson’s.

Latest News from PhRMA

Supporting opportunities for enhanced competition in the marketplace

November 22, 2017

Enhancing the competitive marketplace for biopharmaceuticals is a critical focus for PhRMA.

Read More

New report shows better diabetes management saves money and improves patient outcomes

November 21, 2017

A recent IHS Markit found that controlling diabetes could save more than $4 billion based on Medicaid health care spending in 2016.

Read More

Medicare Monday: PhRMA's comments on new direction for CMMI

November 20, 2017

Today, PhRMA submitted its comments in response to the CMS request for information on the future of CMMI.

Read More

Medicare Monday: Same bad ideas continue to threaten Part D and beneficiary access to medicines

November 13, 2017

Some quick points on why these proposals are bad for Part D.

Read More

Video: What is a results-based contract?

November 13, 2017

Video helps explain how results-based contracts work and how they can impact patients and the health care system.

Read More

Honoring veterans serving in the biopharmaceutical industry

November 11, 2017

In honor of Veterans Day, we spoke with Rob Caskey, a senior manager in PhRMA’s finance department about his military service.

Read More

New report and event examine the new era of vaccines

November 9, 2017

Vaccines play a vital role in protecting public health and preventing deadly disease.

Read More

PhRMA Statement on Report President Commissions’ Final Report with Opioid Recommendations

November 2, 2017

PhRMA is working with the (NIH) and NIDA to establish a public-private partnership that will advance the development of non-addictive pain treatment options.

Read More

Leading Biopharmaceutical Researchers to Showcase the New Era of Medicine on Capitol Hill

November 2, 2017

PhRMA is bringing more than 50 scientists and researchers from America’s biopharmaceutical companies to meet with policymakers and senior staff today on Capitol Hill.

Read More

PhRMA Statement on House Vote to Repeal IPAB

November 2, 2017

PhRMA applauds the House for taking much needed action to repeal the Independent Payment Advisory Board (IPAB). This Board of unelected bureaucrats was given virtually unchecked power to make decisions that impact more than 55 million Medicare beneficiaries – overruling Congress’ authority over the Medicare program and threatening patient access to needed medicines.

Read More
prev 1 2 3 4 5 6 next